Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years

NCT02315352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: L-PZQ ODT
DRUG: Rac-PZQ ODT
DRUG: L-PZQ ODT
DRUG: Rac-PZQ ODT
DRUG: Cesol®

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]